Selected research
Industry Research
Hyaluronic Acid for Osteoarthritis Industry Research Report 2026
Market perspective
The global Hyaluronic Acid for Osteoarthritis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hyaluronic Acid for Osteoarthritis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hyaluronic Acid for Osteoarthritis is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hyaluronic Acid for Osteoarthritis is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hyaluronic Acid for Osteoarthritis include BIOVENTUS, Anika Therapeutics, BIOIBERICA, Biolevox, Bohus BioTech, Fidia Farma, Hangzhou Singclean Medical Products, ideolab and LG Chem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hyaluronic Acid for Osteoarthritis market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hyaluronic Acid for Osteoarthritis Market by Company
BIOVENTUS
Anika Therapeutics
BIOIBERICA
Biolevox
Bohus BioTech
Fidia Farma
Hangzhou Singclean Medical Products
ideolab
LG Chem
Vivacy
Xediton Pharmaceuticals
Deka
Ferring B.V.
Sanofi
Hyaluronic Acid for Osteoarthritis Segment by Type
Single-Phase
Duplex
Hyaluronic Acid for Osteoarthritis Segment by Application
Knee Joint
Hip Joint
Shoulder Joint
Ankle Joint
Others
Hyaluronic Acid for Osteoarthritis Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyaluronic Acid for Osteoarthritis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hyaluronic Acid for Osteoarthritis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyaluronic Acid for Osteoarthritis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hyaluronic Acid for Osteoarthritis manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hyaluronic Acid for Osteoarthritis by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hyaluronic Acid for Osteoarthritis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-Phase
- Duplex
Applications
- Knee Joint
- Hip Joint
- Shoulder Joint
- Ankle Joint
- Others
Companies covered
- BIOVENTUS
- Anika Therapeutics
- BIOIBERICA
- Biolevox
- Bohus BioTech
- Fidia Farma
- Hangzhou Singclean Medical Products
- ideolab
- LG Chem
- Vivacy
- Xediton Pharmaceuticals
- Deka
- Ferring B.V.
- Sanofi
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hyaluronic Acid for Osteoarthritis Market Size (2021-2032)
- 2.2.2 Global Hyaluronic Acid for Osteoarthritis Sales (2021-2032)
- 2.2.3 Global Hyaluronic Acid for Osteoarthritis Market Average Price (2021-2032)
- 2.3 Hyaluronic Acid for Osteoarthritis by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Single-Phase
- 2.3.3 Duplex
- 2.4 Hyaluronic Acid for Osteoarthritis by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Knee Joint
- 2.4.3 Hip Joint
- 2.4.4 Shoulder Joint
- 2.4.5 Ankle Joint
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hyaluronic Acid for Osteoarthritis Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hyaluronic Acid for Osteoarthritis Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Hyaluronic Acid for Osteoarthritis Revenue of Manufacturers (2021-2026)
- 3.4 Global Hyaluronic Acid for Osteoarthritis Average Price by Manufacturers (2021-2026)
- 3.5 Global Hyaluronic Acid for Osteoarthritis Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hyaluronic Acid for Osteoarthritis, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hyaluronic Acid for Osteoarthritis, Product Type & Application
- 3.8 Global Manufacturers of Hyaluronic Acid for Osteoarthritis, Established Date
- 3.9 Global Hyaluronic Acid for Osteoarthritis Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BIOVENTUS
- 4.1.1 BIOVENTUS Company Information
- 4.1.2 BIOVENTUS Business Overview
- 4.1.3 BIOVENTUS Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BIOVENTUS Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.1.5 BIOVENTUS Recent Developments
- 4.2 Anika Therapeutics
- 4.2.1 Anika Therapeutics Company Information
- 4.2.2 Anika Therapeutics Business Overview
- 4.2.3 Anika Therapeutics Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Anika Therapeutics Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.2.5 Anika Therapeutics Recent Developments
- 4.3 BIOIBERICA
- 4.3.1 BIOIBERICA Company Information
- 4.3.2 BIOIBERICA Business Overview
- 4.3.3 BIOIBERICA Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 BIOIBERICA Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.3.5 BIOIBERICA Recent Developments
- 4.4 Biolevox
- 4.4.1 Biolevox Company Information
- 4.4.2 Biolevox Business Overview
- 4.4.3 Biolevox Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Biolevox Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.4.5 Biolevox Recent Developments
- 4.5 Bohus BioTech
- 4.5.1 Bohus BioTech Company Information
- 4.5.2 Bohus BioTech Business Overview
- 4.5.3 Bohus BioTech Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bohus BioTech Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.5.5 Bohus BioTech Recent Developments
- 4.6 Fidia Farma
- 4.6.1 Fidia Farma Company Information
- 4.6.2 Fidia Farma Business Overview
- 4.6.3 Fidia Farma Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Fidia Farma Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.6.5 Fidia Farma Recent Developments
- 4.7 Hangzhou Singclean Medical Products
- 4.7.1 Hangzhou Singclean Medical Products Company Information
- 4.7.2 Hangzhou Singclean Medical Products Business Overview
- 4.7.3 Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.7.5 Hangzhou Singclean Medical Products Recent Developments
- 4.8 ideolab
- 4.8.1 ideolab Company Information
- 4.8.2 ideolab Business Overview
- 4.8.3 ideolab Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 ideolab Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.8.5 ideolab Recent Developments
- 4.9 LG Chem
- 4.9.1 LG Chem Company Information
- 4.9.2 LG Chem Business Overview
- 4.9.3 LG Chem Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 LG Chem Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.9.5 LG Chem Recent Developments
- 4.10 Vivacy
- 4.10.1 Vivacy Company Information
- 4.10.2 Vivacy Business Overview
- 4.10.3 Vivacy Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Vivacy Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.10.5 Vivacy Recent Developments
- 4.11 Xediton Pharmaceuticals
- 4.11.1 Xediton Pharmaceuticals Company Information
- 4.11.2 Xediton Pharmaceuticals Business Overview
- 4.11.3 Xediton Pharmaceuticals Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Xediton Pharmaceuticals Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.11.5 Xediton Pharmaceuticals Recent Developments
- 4.12 Deka
- 4.12.1 Deka Company Information
- 4.12.2 Deka Business Overview
- 4.12.3 Deka Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Deka Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.12.5 Deka Recent Developments
- 4.13 Ferring B.V.
- 4.13.1 Ferring B.V. Company Information
- 4.13.2 Ferring B.V. Business Overview
- 4.13.3 Ferring B.V. Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Ferring B.V. Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.13.5 Ferring B.V. Recent Developments
- 4.14 Sanofi
- 4.14.1 Sanofi Company Information
- 4.14.2 Sanofi Business Overview
- 4.14.3 Sanofi Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Sanofi Hyaluronic Acid for Osteoarthritis Product Portfolio
- 4.14.5 Sanofi Recent Developments
5 Global Hyaluronic Acid for Osteoarthritis Market Scenario by Region
- 5.1 Global Hyaluronic Acid for Osteoarthritis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hyaluronic Acid for Osteoarthritis Sales by Region: 2021-2032
- 5.2.1 Global Hyaluronic Acid for Osteoarthritis Sales by Region: 2021-2026
- 5.2.2 Global Hyaluronic Acid for Osteoarthritis Sales by Region: 2027-2032
- 5.3 Global Hyaluronic Acid for Osteoarthritis Revenue by Region: 2021-2032
- 5.3.1 Global Hyaluronic Acid for Osteoarthritis Revenue by Region: 2021-2026
- 5.3.2 Global Hyaluronic Acid for Osteoarthritis Revenue by Region: 2027-2032
- 5.4 North America Hyaluronic Acid for Osteoarthritis Market Facts & Figures by Country
- 5.4.1 North America Hyaluronic Acid for Osteoarthritis Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2032)
- 5.4.3 North America Hyaluronic Acid for Osteoarthritis Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Hyaluronic Acid for Osteoarthritis Market Facts & Figures by Country
- 5.5.1 Europe Hyaluronic Acid for Osteoarthritis Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2032)
- 5.5.3 Europe Hyaluronic Acid for Osteoarthritis Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Hyaluronic Acid for Osteoarthritis Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hyaluronic Acid for Osteoarthritis Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hyaluronic Acid for Osteoarthritis Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hyaluronic Acid for Osteoarthritis Market Facts & Figures by Country
- 5.7.1 South America Hyaluronic Acid for Osteoarthritis Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2032)
- 5.7.3 South America Hyaluronic Acid for Osteoarthritis Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Hyaluronic Acid for Osteoarthritis Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hyaluronic Acid for Osteoarthritis Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hyaluronic Acid for Osteoarthritis Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Hyaluronic Acid for Osteoarthritis Sales by Type (2021-2032)
- 6.1.1 Global Hyaluronic Acid for Osteoarthritis Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Type (2021-2032)
- 6.2 Global Hyaluronic Acid for Osteoarthritis Revenue by Type (2021-2032)
- 6.2.1 Global Hyaluronic Acid for Osteoarthritis Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Type (2021-2032)
- 6.3 Global Hyaluronic Acid for Osteoarthritis Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hyaluronic Acid for Osteoarthritis Sales by Application (2021-2032)
- 7.1.1 Global Hyaluronic Acid for Osteoarthritis Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Application (2021-2032)
- 7.2 Global Hyaluronic Acid for Osteoarthritis Revenue by Application (2021-2032)
- 7.2.1 Global Hyaluronic Acid for Osteoarthritis Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Application (2021-2032)
- 7.3 Global Hyaluronic Acid for Osteoarthritis Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hyaluronic Acid for Osteoarthritis Value Chain Analysis
- 8.1.1 Hyaluronic Acid for Osteoarthritis Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hyaluronic Acid for Osteoarthritis Production Mode & Process
- 8.2 Hyaluronic Acid for Osteoarthritis Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hyaluronic Acid for Osteoarthritis Distributors
- 8.2.3 Hyaluronic Acid for Osteoarthritis Customers
9 Global Hyaluronic Acid for Osteoarthritis Analyzing Market Dynamics
- 9.1 Hyaluronic Acid for Osteoarthritis Industry Trends
- 9.2 Hyaluronic Acid for Osteoarthritis Industry Drivers
- 9.3 Hyaluronic Acid for Osteoarthritis Industry Opportunities and Challenges
- 9.4 Hyaluronic Acid for Osteoarthritis Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst